Clinical trial
Combined Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic Plasmacytoid Dendritic Cells in Defining Disease Course in Multiple Sclerosis Patients
NCT05451069 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combined Neurofilament Light Chain ,Chitinase-3 Like-1 Protein Levels and Tolerogenic Plasmacytoid Dendritic Cells in Defining Disease Course in Multiple Sclerosis Patients
- Lead sponsor
- Assiut University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 1, 2022
- Completion date
- July 27, 2025
- Enrollment
- 42 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.